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Clinical and cultural 
conflicts
As a GP working in the Middle East, I can 
totally understand Dr Sherifi’s concern.1 
Unfortunately end-of-life care and palliative 
care medicine are in their infancy. This is 
because of a lot of cultural and religious 
factors held by both patients’ families 
and healthcare professionals. In some 
of the Gulf countries, the do not attempt 
resuscitation (DNAR) forms and decision 
were just introduced a few months ago. 
However, I hear from colleagues in critical 
care who received complaints from fellow 
staff members despite family approval, for 
interfering with God’s will or acting like 
God by withdrawing treatment. I have to 
say it is a very difficult situation for the 
doctors working there and they just simply 
have to abide by the rules of the land. I am 
sorry that your uncle and family have to go 
through this distress.
Yusr Jaafir,
Family Medicine Consultant/GP, OPD. 
E-mail: yusr79@gmail.com
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Discharge summary 
information: more than 
DVT warnings needed
My out-of-hours duty shift today echoed 
this article.1 While recognising that usually 
it should be the family and perhaps the 
family doctor to get involved proactively, 
perhaps we should suggest to our 
colleagues in hospital that it would be far 
more useful on discharge summaries of 
the frail and declining group of patients 
that end-of-life care, choice of place to 
die, wishes for readmission, and do not 
attempt resuscitation (DNAR) had all been 
discussed rather than documenting that 
they have been warned about DVT.
In my personal view we should also move 
away from the need to have a DNAR form 
to allow someone to peacefully die. Putting 
these responsibilities onto the visiting out-
of-hours team with no prior knowledge is 
neither safe or fair.
Nicholas J Sharvill,
GP, Portfolio GP including out of hours. 
E-mail: john.sharvill@nhs.net
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The role of general 
practice in surgical 
trials
We read with much interest the editorial 
by Keshav and Stevens,1 which discusses 
a broad overview of the advancements in 
the knowledge of iron deficiency anaemia 
(IDA) with emphasis on management. We 
encourage GPs and community medicine 
to engage in the research on the condition, 
which remains one of the greatest burdens 
to global health.2 Their comments regarding 
implementation of parenteral iron therapy 
to manage IDA is of particular importance 
for a number of reasons. 
The awareness of and education 
currently available to GPs for IDA does not 
reflect major advances in the aetiology and 
particularly the unrecognised impact on 
patient welfare. This has led to considerable 
under-management of IDA. For example, a 
large percentage (the average being 30%) 
of elective surgical patients, many of whom 
are pre-emptively referred by GPs, are 
in fact found to have IDA.3 Preoperative 
anaemia is independently associated 
with poorer outcomes.4 Recognising 
and managing preoperative anaemia is 
supported by authoritative bodies such as 
the Association of Anaesthetists of Great 
Britain and Ireland (AAGBI), NHS Blood 
and Transplant (NHSBT), and the National 
Institute for Health and Care Excellence 
(NICE).
However, it is not clear whether 
intravenous iron is the optimal treatment 
option in this setting. The Preoperative 
intravenous (IV) iron to treat anaemia in 
major abdominal surgery (PREVENTT)9 
phase III randomised controlled trial 
addresses this question of whether 
intravenous iron can effectively treat 
anaemia and improve patient outcomes 
in the surgical patient.5 One issue is that 
screening data have revealed the difficulties 
and a major issue of patients being referred 
for operations not having simple blood tests 
such as a full blood count or electrolytes. In 
the referral to treatment, 18-week pathway, 
this is often overlooked to meet timelines. 
We ask for the general practice 
community to join us and contribute to 
this research with the end goal to improve 
patient outcome. Our emphasis placed on 
education and awareness of IDA, ensuring 
patients are identified, with the inclusion of 
up-to-date blood tests prior to referral to 
tertiary hospitals. Engagement with general 
practice with time to pre-optimise patients, 
diagnose the cause of anaemia, and develop 
a patient blood management plan would be 
a substantial contribution to the improved 
management of this condition.
Anna Butcher,
Division of Surgery and Interventional 
Science, University College London, 
London. 
E-mail: a.butcher@ucl.ac.uk
Rebecca Swinson,
London School of Hygiene and Tropical 
Medicine, London.
Laura VanDyck,
London School of Hygiene and Tropical 
Medicine, London.
Tim Collier,
London School of Hygiene and Tropical 
Medicine, London.
Toby Richards,
Division of Surgery and Interventional 
Science, University College London, 
London.
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Do primary care 
chaplains need training 
in mental health 
issues?
I read with interest Dr Macdonald’s 
article, which showed that talking therapy 
by chaplains resulted in an equivalent 
improvement in patient wellbeing as 
antidepressants.1
Leavey et al2 in an interview study 
concluded that clergy tend to explain mental 
health problems in terms of social factors 
with spiritual influences and for them the 
meaning of mental distress assumes more 
social and moral significance. Pennybaker 
et al3 have suggested there is a need to 
provide chaplains with training in psychiatric 
illness and to more clearly define their role 
in mental health care.
Dr Macdonald suggests primary care 
chaplaincy could be considered as an 
alternative to cognitive behavioural therapy 
but before adopting this strategy more 
widely it would be useful to obtain the views 
of chaplains on what talking therapy means 
to them and what training they would need 
to provide it.
Ian J Hamilton,
Researcher, Institute of Health and 
Wellbeing, University of Glasgow. 
E-mail: ijdhamilton@doctors.org.uk
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Incorporating cancer 
risk information into 
general practice: a 
qualitative study using 
focus groups with 
health professionals
Usher-Smith et al report a useful study 
in the potential utility of cancer risk 
assessment tools in general practice.1 
Readers may be interested to know that the 
www.qcancer.org tool, which calculates risk 
of a current but as yet undiagnosed cancer, 
was integrated into EMISWeb in 2016; the 
most popular GP computer system, used by 
over 55% of all GPs in the UK.
Also there is a new tool that predicts 
10-year risk of different types of cancer, 
taking account of family history and lifestyle 
as well as other risk factors that are readily 
available.2 There is an online calculator for 
women (http://qcancer.org/10yr/female/) and 
one for men (http://qcancer.org/10yr/male/).
Julia Hippisley-Cox,
Professor of Clinical Epidemiology and 
General Practice, University of Nottingham, 
and ClinRisk Ltd. 
E-mail: julia.hippisley-cox@nottingham.ac.uk
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The wrong paradigm 
may be driving drug 
glucose control in the 
face of the evidence
Boussageon et al are the latest to highlight 
the apparent contradiction in our current 
thinking.1
On the one hand, the epidemiological 
evidence shows a strong link between 
chronic hyperglycaemia (HbA1c) and 
adverse patient-important outcomes. On the 
other hand, the evidence from randomised 
controlled trial shows that lowering HbA1c 
by drug treatment is ineffective or harmful 
to patient outcomes.
This contradiction is because we are 
using the wrong paradigm.
The current paradigm is that HbA1c has a 
causal relationship with adverse outcomes 
and that lowering HbA1c by any means 
must improve patient-important outcomes. 
The alternative paradigm is that chronic 
hyperglycaemia is partly causal, but is only 
a late and easily measurable part of a more 
fundamental problem.
Our culturally ‘normal’ diet, based on 
carbohydrate, is biologically different from 
the diet the human species evolved to thrive 
on. A large proportion of people cannot 
tolerate a carbohydrate-based diet over 
years, even ‘healthy whole grains’. Eating 
starch is eating glucose, which requires a 
corresponding insulin response. An insulin 
response with every snack and meal for years 
can, in genetically vulnerable people, cause 
insulin resistance with variable expression 
among people and among different body 
tissues. The Hyperinsulinaemia and Insulin 
Resistance (HAIR) is the underlying problem 
driving disorders of glucose and lipid 
metabolism, characterised by pathological 
fat deposition as central and visceral 
obesity, metabolic syndrome, and, when 
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